CTC Clinical Trial Consultants AB Revenue and Competitors
Estimated Revenue & Valuation
- CTC Clinical Trial Consultants AB's estimated annual revenue is currently $32M per year.
- CTC Clinical Trial Consultants AB's estimated revenue per employee is $201,000
Employee Data
- CTC Clinical Trial Consultants AB has 159 Employees.
- CTC Clinical Trial Consultants AB grew their employee count by 5% last year.
CTC Clinical Trial Consultants AB's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Safety Officer | Reveal Email/Phone |
3 | Safety Officer & Medical Coder | Reveal Email/Phone |
4 | Director New Technology | Reveal Email/Phone |
5 | Director Biometrics | Reveal Email/Phone |
6 | Director DMPK and Clinical Pharmacology | Reveal Email/Phone |
7 | Chief Commercial Officer | Reveal Email/Phone |
8 | Chief Scientific Officer / Senior Medical Writer | Reveal Email/Phone |
9 | Chairman and Senior Scientific Officer | Reveal Email/Phone |
10 | Chief Medical Officer (CMO) | Reveal Email/Phone |
CTC Clinical Trial Consultants AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6830.1M | 21238 | 5% | N/A | N/A |
#2 | $773.8M | 3120 | 8% | $1.8M | N/A |
#3 | $288.6M | 1436 | 13% | N/A | N/A |
#4 | $2.5M | 25 | N/A | N/A | N/A |
What Is CTC Clinical Trial Consultants AB?
CTC Clinical Trial Consultants AB will provide you with company updates on this page. When we hire new staff, company news etc. Phase 0, Site Management Organisation, Phase 1, PET, Microdose, CLAMP Studies, First time in Human Studies, PK/PD analysis, Project Management, iCardiac’s Early Precision QT® (EPQT), SAD/MAD studies, Functional Food, Bioequivalence, PET/MR, PET/CT, Patient Recruitment
keywords:N/AN/A
Total Funding
159
Number of Employees
$32M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $33.5M | 159 | 3% | N/A |
#2 | $25.4M | 159 | 24% | N/A |
#3 | $47.2M | 159 | 62% | N/A |
#4 | $57.7M | 159 | 0% | N/A |
#5 | $35.4M | 160 | N/A | N/A |